China Traditional Chinese Medicine Holdings Co Ltd Relative Valuation - China Traditional Chinese Medicine Holdings Co Ltd

Watchlist Manager

Watchlist

Price: 2.01 HKD -2.43%

Market Cap: 10.1B HKD

Section:

Relative Value

The Relative Value of one China Traditional Chinese Medicine Holdings Co Ltd stock under the Base Case scenario is 3.85 HKD. Compared to the current market price of 2.01 HKD, China Traditional Chinese Medicine Holdings Co Ltd is Undervalued by 48%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is Relative Valuation?

How is Relative Value calculated?

Relative Value

Base Case

Worst Case

Base Case

Best Case

Valuation Multiples

0.5

P/S

vs History	95
vs Industry	81

Median 5Y

Industry

2.4

Forward

0.6

More Details

10.3

P/E

vs History	61
vs Industry	38

Median 5Y

11.3

Industry

20.5

Forward

More Details

P/OCF

vs History	95
vs Industry	49

Median 5Y

14.3

Industry

15.4

More Details

Negative

P/FCFE

vs History
vs Industry	16

Median 5Y

-28.6

Industry

22.6

More Details

0.4

P/B

vs History	95
vs Industry	76

Median 5Y

0.9

Industry

More Details

0.4

EV/S

vs History	93
vs Industry	87

Median 5Y

0.8

Industry

2.5

Forward

0.5

More Details

0.8

EV/GP

vs History	93
vs Industry	85

Median 5Y

1.4

Industry

4.9

More Details

7.4

EV/EBITDA

vs History	22
vs Industry	39

Median 5Y

5.9

Industry

12.6

Forward

4.7

More Details

7.4

EV/EBIT

vs History	41
vs Industry	42

Median 5Y

6.8

Industry

15.6

Forward

15.7

More Details

2.9

EV/OCF

vs History	95
vs Industry	51

Median 5Y

10.8

Industry

13.9

More Details

3.6

EV/FCFF

vs History	66
vs Industry	38

Median 5Y

15.5

Industry

17.7

More Details

0.3

EV/IC

vs History	92
vs Industry	80

Median 5Y

0.5

Industry

1.8

More Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

			Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
HK	C	China Traditional Chinese Medicine Holdings Co Ltd HKEX:570	10.1B HKD	0.5	10.3	7.4	7.4
US		Eli Lilly and Co NYSE:LLY	778.6B USD	17.3	73.5	42.7	47.2
UK		Dechra Pharmaceuticals PLC LSE:DPH	440.4B GBP	578.3	-15 783.5	3 846.3	17 702.3
US		Johnson & Johnson NYSE:JNJ	392.6B USD	4.4	27.9	13.1	17.1
DK		Novo Nordisk A/S CSE:NOVO B	2.1T DKK	7.3	21	13.8	15.7
CH		Roche Holding AG SIX:ROG	236.1B CHF	4	20.5	11.5	13.6
CH		Novartis AG SIX:NOVN	199.5B CHF	4.4	18.9	11.4	14.7
UK		AstraZeneca PLC LSE:AZN	176.2B GBP	4.2	32.4	126.9	193.8
US		Merck & Co Inc NYSE:MRK	221.8B USD	3.5	13	8.8	10.4
IE	E	Endo International PLC LSE:0Y5F	167.6B USD	72.3	-57.3	267.5	670.8
US		Pfizer Inc NYSE:PFE	141.7B USD	2.2	17.6	8.5	12.1

				Revenue Growth	P/S to Growth
HK	C	China Traditional Chinese Medicine Holdings Co Ltd HKEX:570	Average P/S: 63.5 0.5	-1%	N/A
US		Eli Lilly and Co NYSE:LLY	17.3	22%	0.8
UK		Dechra Pharmaceuticals PLC LSE:DPH	578.3	9%	64.3
US		Johnson & Johnson NYSE:JNJ	4.4	3%	1.5
DK		Novo Nordisk A/S CSE:NOVO B	7.3	17%	0.4
CH		Roche Holding AG SIX:ROG	4	5%	0.8
CH		Novartis AG SIX:NOVN	4.4	3%	1.5
UK		AstraZeneca PLC LSE:AZN	4.2	7%	0.6
US		Merck & Co Inc NYSE:MRK	3.5	5%	0.7
IE	E	Endo International PLC LSE:0Y5F	72.3	N/A	N/A
US		Pfizer Inc NYSE:PFE	2.2	0%	N/A

				Earnings Growth	PEG
HK	C	China Traditional Chinese Medicine Holdings Co Ltd HKEX:570	Average P/E: 26.1 10.3	-6%	N/A
US		Eli Lilly and Co NYSE:LLY	73.5	48%	1.5
UK		Dechra Pharmaceuticals PLC LSE:DPH	Negative Multiple: -15 783.5	N/A	N/A
US		Johnson & Johnson NYSE:JNJ	27.9	26%	1.1
DK		Novo Nordisk A/S CSE:NOVO B	21	19%	1.1
CH		Roche Holding AG SIX:ROG	20.5	16%	1.3
CH		Novartis AG SIX:NOVN	18.9	16%	1.2
UK		AstraZeneca PLC LSE:AZN	32.4	36%	0.9
US		Merck & Co Inc NYSE:MRK	13	17%	0.8
IE	E	Endo International PLC LSE:0Y5F	Negative Multiple: -57.3	N/A	N/A
US		Pfizer Inc NYSE:PFE	17.6	29%	0.6

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication

	Franklin Covey Co NYSE:FC	28.1 USD -1.89%
	Mohawk Industries Inc NYSE:MHK	117.19 USD 0.28%
	Ardmore Shipping Corp NYSE:ASC	10.04 USD -0.4%
	ASGN Inc NYSE:ASGN	64.22 USD -0.17%
	Skyworks Solutions Inc NASDAQ:SWKS	66.3 USD -1.92%
	Weatherford International PLC NASDAQ:WFRD	54.69 USD -2.36%

	Johnson & Johnson NYSE:JNJ	163.13 USD 0.87%
	Bank of America Corp NYSE:BAC	42.56 USD -0.61%
	Mastercard Inc NYSE:MA	557.57 USD 1.55%
	Salesforce Inc NYSE:CRM	277.81 USD -1.13%
	Abbvie Inc NYSE:ABBV	202.72 USD 0.71%
	Home Depot Inc NYSE:HD	362.73 USD 0.17%

	Arista Networks Inc NYSE:ANET	78.96 USD -3.31%
	Visa Inc NYSE:V	349.86 USD 1.65%
	Texas Pacific Land Corp NYSE:TPL	1 331.91 USD -1.98%
	KLA Corp NASDAQ:KLAC	700 USD -0.79%
	Manhattan Associates Inc NASDAQ:MANH	174.82 USD -0.46%
	Monolithic Power Systems Inc NASDAQ:MPWR	601.44 USD 0.16%

	ServiceNow Inc NYSE:NOW	827.74 USD -1.29%
	EOG Resources Inc NYSE:EOG	126.73 USD -1.9%
	Monster Beverage Corp NASDAQ:MNST	58.58 USD 1.42%
	Applied Materials Inc NASDAQ:AMAT	147.68 USD -1.99%
	Airbnb Inc NASDAQ:ABNB	125.65 USD -2.32%
	Synopsys Inc NASDAQ:SNPS	446.23 USD -0.82%

China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570

Relative Value

Valuation Multiples

Multiples Across Competitors

Competitors Multiples
China Traditional Chinese Medicine Holdings Co Ltd Competitors

See Also

Company

Help

Tools

Stocks

				EBITDA Growth	EV/EBITDA to Growth
HK	C	China Traditional Chinese Medicine Holdings Co Ltd HKEX:570	Average EV/EBITDA: 396.2 7.4	-4%	N/A
US		Eli Lilly and Co NYSE:LLY	42.7	30%	1.4
UK		Dechra Pharmaceuticals PLC LSE:DPH	3 846.3	36%	106.8
US		Johnson & Johnson NYSE:JNJ	13.1	7%	1.9
DK		Novo Nordisk A/S CSE:NOVO B	13.8	15%	0.9
CH		Roche Holding AG SIX:ROG	11.5	8%	1.4
CH		Novartis AG SIX:NOVN	11.4	5%	2.3
UK		AstraZeneca PLC LSE:AZN	126.9	9%	14.1
US		Merck & Co Inc NYSE:MRK	8.8	9%	1
IE	E	Endo International PLC LSE:0Y5F	267.5	N/A	N/A
US		Pfizer Inc NYSE:PFE	8.5	3%	2.8

				EBIT Growth	EV/EBIT to Growth
HK	C	China Traditional Chinese Medicine Holdings Co Ltd HKEX:570	Average EV/EBIT: 1 700.5 7.4	0%	N/A
US		Eli Lilly and Co NYSE:LLY	47.2	33%	1.4
UK		Dechra Pharmaceuticals PLC LSE:DPH	17 702.3	98%	180.6
US		Johnson & Johnson NYSE:JNJ	17.1	12%	1.4
DK		Novo Nordisk A/S CSE:NOVO B	15.7	16%	1
CH		Roche Holding AG SIX:ROG	13.6	9%	1.5
CH		Novartis AG SIX:NOVN	14.7	8%	1.8
UK		AstraZeneca PLC LSE:AZN	193.8	21%	9.2
US		Merck & Co Inc NYSE:MRK	10.4	12%	0.9
IE	E	Endo International PLC LSE:0Y5F	670.8	N/A	N/A
US		Pfizer Inc NYSE:PFE	12.1	10%	1.2

52 Week Range	1.87 4.43
Price Target

China Traditional Chinese Medicine Holdings Co Ltd HKEX:570

Relative Value

Valuation Multiples

Multiples Across Competitors

Competitors Multiples China Traditional Chinese Medicine Holdings Co Ltd Competitors

See Also

Company

Help

Tools

Stocks

China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570

Competitors Multiples
China Traditional Chinese Medicine Holdings Co Ltd Competitors